Co-Authors
This is a "connection" page, showing publications co-authored by Sophie Trouillet-Assant and Jean-Baptiste Fassier.
Connection Strength
0.944
-
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 Oct 04; 218(10).
Score: 0.241
-
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 10 04; 218(10).
Score: 0.240
-
Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study. BMJ Open. 2020 11 24; 10(11):e041268.
Score: 0.229
-
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study. Sci Rep. 2021 07 22; 11(1):14977.
Score: 0.060
-
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test. Clin Chem. 2021 04 29; 67(5):742-752.
Score: 0.059
-
Type-I Interferon assessment in 45 minutes using the FilmArray® PCR platform in SARS-CoV-2 and other viral infections. Eur J Immunol. 2021 04; 51(4):989-994.
Score: 0.058
-
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays. Clin Microbiol Infect. 2021 Jun; 27(6):933-935.
Score: 0.058